The likely win is better monetization of scarce assets, not another dramatic
rerating. Constellation should improve revenue quality as more nuclear output, gas-backed
large-load capacity and site services move into longer-duration contracts, while
Calpine broadens its shaped-power offering. That supports solid compounding, but today’s starting valuation already reflects much of the scarcity story, so most upside should come from execution and earnings growth rather than multiple expansion.